News on genome-wide association studies, genotyping, metagenomics, basic research in genetics, genomics, and molecular diagnostics.
The company also said it will release its first polygenic risk score for cardiovascular disease early this year.
The studies involved data from 14,000 Hispanic women and showed the 87-SNP risk score outperformed its 86-SNP score for European women.
KMPJM will provide diagnostic and prognostic testing services based on genes, proteins, and other molecules to aid physicians in assessing and treating patients.
